USP21 and colorectal carcinoma: Compared with the high USP21 group, patients in the low USP21 group had lower IC50 to targeted drugs, such as sunitinib, temsirolimus, DMOG, and NVP.BEZ235, indicating that CRC with low USP21 was more sensitive to these drugs (Fig. 7B).